Pharmacists can play a key role in patient counseling and ensuring medication adherence, especially in the treatment of patients with cancer. Though therapies for multiple myeloma (MM) have shown efficacy in prolonging patient overall survival and progression-free survival, they are associated with unique adverse effect profiles. This podcast discussion will center on strategies for pharmacists to mitigate toxicity and implement appropriate supportive care for patients with MM.
Target audience: Health System Pharmacist, Oncology Pharmacist, Specialty Pharmacist, Pharmacist Technicians
Type of activity: Application
Release date: July 11, 2022
Expiration date: July 11, 2023
Time to complete activity: 0.5 hours
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Describe a strategy to mitigate potential adverse effects of multiple myeloma therapies by altering the route of administration, dosing schedule, and use of supportive care medications
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
